Moreover, considering that treatment with NF-kB inhibitors decreased osteoarthritis [56] and inflammatory pain [57], the reversion of CFA-generated p-IKBα up-regulation in the paw with HRW treatment suggested that these anti-inflammatory actions might also be involved in its analgesic effects. The gene discussed is NFKBIA; the disease is osteoarthritis.